Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Libman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Stroke|September 6, 2008
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trialArthur M Pancioli, Joseph Broderick, Thomas Brott, et al.
The Lancet. Neurology|June 21, 2020
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trialJay P Mohr, Jessica R Overbey, Andreas Hartmann, et al.
Neurology|September 8, 2017
Functional impairments for outcomes in a randomized trial of unruptured brain AVMsJ P Mohr, Jessica R Overbey, Ruediger von Kummer, et al.
Lancet (London, England)|November 26, 2013
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ P Mohr, Michael K Parides, Christian Stapf, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Stroke|September 6, 2008
The combined approach to lysis utilizing eptifibatide and rt-PA in acute ischemic stroke: the CLEAR stroke trialArthur M Pancioli, Joseph Broderick, Thomas Brott, et al.
The Lancet. Neurology|June 21, 2020
Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trialJay P Mohr, Jessica R Overbey, Andreas Hartmann, et al.
Neurology|September 8, 2017
Functional impairments for outcomes in a randomized trial of unruptured brain AVMsJ P Mohr, Jessica R Overbey, Ruediger von Kummer, et al.
Lancet (London, England)|November 26, 2013
Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trialJ P Mohr, Michael K Parides, Christian Stapf, et al.
Pageof 3